Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1798]
News [2692]
Articles [197]
Editorials [1]
Conferences [135]
elearning [13]
Diverse genetic alterations in triple-negative breast cancers after neoadjuvant...
Dr Justin Balko - Vanderbilt-Ingram Cancer Center, Nashville, USA
Diverse genetic alterations in triple-negative breast cancers after neoadjuvant chemotherapy ( Dr Justin Balko - Vanderbilt-Ingram Cancer Center, Nashville, USA )
6 Dec 2012
Young women with breast cancer more likely to respond to neoadjuvant...
Prof Sibylle Loibl - University of Frankfurt, Frankfurt, Germany
Young women with breast cancer more likely to respond to neoadjuvant chemotherapy ( Prof Sibylle Loibl - University of Frankfurt, Frankfurt, Germany )
6 Dec 2012
Chemo after complete surgical removal of local or regional breast cancer...
Dr Stefan Aebi - Luzerner Kantonsspital, Luzern, Switzerland
Chemo after complete surgical removal of local or regional breast cancer recurrence increases survival rates ( Dr Stefan Aebi - Luzerner Kantonsspital, Luzern, Switzerland )
6 Dec 2012
Transcriptional regulation of endothelial cell differentiation
Dr Elisabetta Dejana – IFOM – University of Milan, Italy
Transcriptional regulation of endothelial cell differentiation ( Dr Elisabetta Dejana – IFOM – University of Milan, Italy )
22 Nov 2012
Highlights from the 4th EUTROC meeting
Prof John Green – University of Liverpool, UK
Highlights from the 4th EUTROC meeting ( Prof John Green – University of Liverpool, UK )
15 Nov 2012
The AKT pathway and chemotherapy resistant ovarian cancer
Dr Euan Stronach – Imperial College London, UK
The AKT pathway and chemotherapy resistant ovarian cancer ( Dr Euan Stronach – Imperial College London, UK )
15 Nov 2012
Therapeutic exercise for patients with advanced cancer
Dr Matthew Maddocks – University of Nottingham, UK
Therapeutic exercise for patients with advanced cancer ( Dr Matthew Maddocks – University of Nottingham, UK )
14 Nov 2012
Development of future cancer treatments
Dr Herbie Newell - Northern Institute for Cancer Research, Newcastle, UK
Development of future cancer treatments ( Dr Herbie Newell - Northern Institute for Cancer Research, Newcastle, UK )
14 Nov 2012
Influence of cachexia on chemotherapy toxicity
Dr Michael Sawyer – University of Alberta, Canada
Influence of cachexia on chemotherapy toxicity ( Dr Michael Sawyer – University of Alberta, Canada )
14 Nov 2012
Phase III HECTOR study: recurring platinum sensitive ovarian cancer
Prof Sven Mahner - University Medical Center Hamburg-Eppendorf , Hamburg...
Phase III HECTOR study: recurring platinum sensitive ovarian cancer ( Prof Sven Mahner - University Medical Center Hamburg-Eppendorf , Hamburg, Germany )
31 Oct 2012
GOG 209 study: optimal management of advanced endometrial cancer
Prof David Miller – University of Texas Southwestern Medical Centre, Dallas, USA
GOG 209 study: optimal management of advanced endometrial cancer ( Prof David Miller – University of Texas Southwestern Medical Centre, Dallas, USA )
31 Oct 2012
AURELIA trial, palliative chemotherapy with bevacizumab in resistant, recurrent...
Dr Gunnar Kristensen – Norwegian Radium Hospital, Oslo, Norway
AURELIA trial, palliative chemotherapy with bevacizumab in resistant, recurrent ovarian cancer ( Dr Gunnar Kristensen – Norwegian Radium Hospital, Oslo, Norway )
30 Oct 2012

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation